PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#oral antibiotics ×

UPDATED
Regulatory Updates
Sep 24, 2026•1 min read
FDA Approves Alembic’s Nitrofurantoin Generic Capsules (ANDA211935)
The FDA has approved Alembic Pharmaceuticals’ generic Nitrofurantoin capsules (ANDA211935) for oral prescription use in 25 mg, 50 mg, and 100 mg strengths.